03.24.23
Board members of LTS Lohmann Therapie-Systeme AG (LTS) together with the outgoing mayor of the city of Andernach, Germany, and his successor performed the groundbreaking ceremony for the future LTS Technikum. This is another building block in a series of investments that will keep the Andernach site modern and fit for the future, says the company. In addition to the new Technical Center, expansion areas are being created for LTS production. The building and energy supply will be constructed in accordance with the latest energy standards.
The new LTS Technical Center offers space to bring together expertise from pharmaceutical development, technology, and manufacturing. Here, new developments and solutions to problems are developed for external and internal customers. The premises provide the developers and engineers with plenty of space to develop future technologies and make them marketable. A large showroom offers customers and visitors the opportunity to gain an insight into the latest developments at LTS, as well as space for creative exchange, presentations, and discussions.
Part of the building also holds space for the expansion of production, because LTS is counting on further growth. The investment volume for this 7,250 square meter building project is around €30 million.
“We are proud to have taken the first step towards a new milestone in the history of LTS with this ground-breaking ceremony,” said Michael Hoffmann, chief operating officer, LTS. “The LTS Technical Center will make an important contribution to securing market leadership in our market segment.”
LTS Lohmann Therapie-Systeme AG is a pharmaceutical technology company that develops and manufactures drug delivery systems such as transdermal patches and oral thin films.
The new LTS Technical Center offers space to bring together expertise from pharmaceutical development, technology, and manufacturing. Here, new developments and solutions to problems are developed for external and internal customers. The premises provide the developers and engineers with plenty of space to develop future technologies and make them marketable. A large showroom offers customers and visitors the opportunity to gain an insight into the latest developments at LTS, as well as space for creative exchange, presentations, and discussions.
Part of the building also holds space for the expansion of production, because LTS is counting on further growth. The investment volume for this 7,250 square meter building project is around €30 million.
“We are proud to have taken the first step towards a new milestone in the history of LTS with this ground-breaking ceremony,” said Michael Hoffmann, chief operating officer, LTS. “The LTS Technical Center will make an important contribution to securing market leadership in our market segment.”
LTS Lohmann Therapie-Systeme AG is a pharmaceutical technology company that develops and manufactures drug delivery systems such as transdermal patches and oral thin films.
